Clinical Trial Detail

NCT ID NCT02535533
Title SLM + Axitinib for Clear Cell RCC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Iowa
Indications

clear cell renal cell carcinoma

Therapies

Axitinib + Selenomethionine

Age Groups: adult

No variant requirements are available.